MedTrace Logo

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

NCT02387619 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2016-06-24

No results posted yet for this study

Summary

A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic drug interaction between rosuvastatin and telmisartan/amlodipine in healthy male volunteers

Conditions

Interventions

DRUG

Rosuvastatin

Rosuvastatin and Telmisartan/Amlodipine: Rosuvastatin once daily for 9 days

DRUG

Telmisartan/Amlodipine

Rosuvastatin and Telmisartan/Amlodipine: Telmisartan/Amlodipine once daily for 9 days

DRUG

Rosuvastatin and Telmisartan/Amlodipine

Rosuvastatin and Telmisartan/Amlodipine: Rosuvastatin and Telmisartan/Amlodipine once daily for 9days

Sponsors & Collaborators

  • Jeil Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Kyungsoo Park, MD, Ph.D. · Yonsei University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-03-31
Completion
2015-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02387619 on ClinicalTrials.gov